JOHNSON & JOHNSON — Investor Relations & Filings
Filings indexed
3,142
across all filing types
Latest filing
2011-05-10
Director's Dealing
Country
US
United States of America
Listing
US
JNJ
Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PRIMARY DOCUMENT | 2011-05-10 | English | |
| FORM 10-Q | 2011-05-10 | English | |
| Regulatory Filings 2011 | 2011-05-09 | English | |
| PRIMARY DOCUMENT | 2011-05-05 | English | |
| Regulatory Filings 2011 | 2011-05-05 | English | |
| PRIMARY DOCUMENT | 2011-05-04 | English |
Browse filings by year
27 years- 2026 49 filings
- 2025 143 filings
- 2024 157 filings
- 2023 176 filings
- 2022 136 filings
- 2021 88 filings
- 2020 128 filings
- 2019 78 filings
- 2018 85 filings
- 2017 91 filings
- 2016 101 filings
- 2015 86 filings
- 2014 99 filings
- 2013 97 filings
- 2012 105 filings
- 2011 163 filings
- 2010 131 filings
- 2009 142 filings
- 2008 155 filings
- 2007 155 filings
- 2006 174 filings
- 2005 151 filings
- 2004 165 filings
- 2003 158 filings
- 2002 71 filings
- 2001 38 filings
- 2000 20 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2011
15 filings
| |||||
| 15048215 | PRIMARY DOCUMENT | 2011-05-10 | English | ||
| 15048219 | FORM 10-Q | 2011-05-10 | English | ||
| 15048216 | Regulatory Filings 2011 | 2011-05-09 | English | ||
| 15048217 | PRIMARY DOCUMENT | 2011-05-05 | English | ||
| 15048218 | Regulatory Filings 2011 | 2011-05-05 | English | ||
| 15048222 | PRIMARY DOCUMENT | 2011-05-04 | English | ||
| 17505247 | 425 Filing | 2011-05-04 | English | ||
| 17505219 | 425 Filing | 2011-05-04 | English | ||
| 15048220 | CURRENT REPORT | 2011-05-02 | English | ||
| 15048223 | 8-K ANNUAL MEETING | 2011-04-29 | English | ||
| 17505231 | 425 Filing | 2011-04-29 | English | ||
| 17505213 | 425 Filing | 2011-04-29 | English | ||
| 15048221 | 8-K J&J TO ACQUIRE SYNTHES | 2011-04-27 | English | ||
| 17505201 | 425 Filing | 2011-04-27 | English | ||
| 15048225 | DEFA 14A | 2011-04-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
JOHNSON & JOHNSON via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29750/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29750 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29750 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29750 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29750}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for JOHNSON & JOHNSON (id: 29750)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.